Royal Fund Management, LLC Moderna, Inc. Call Options Transaction History

Royal Fund Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 11, 2024	BUY	$85.37 - $115.44 $495,146 - $669,552	5,800 New	5,800 $618,000
Q3 2023 Oct 17, 2023	SELL	$96.41 - $126.61 $212,102 - $278,542	-2,200 Reduced 40.74%	3,200 $330,000
Q2 2023 Jul 12, 2023	BUY	$118.5 - $160.53 $201,450 - $272,901	1,700 Added 45.95%	5,400 $656,000
Q1 2023 Apr 10, 2023	BUY	$135.66 - $197.02 $501,942 - $728,974	3,700 New	3,700 $568,000

913

236M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Royal Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Royal Fund Management, LLC with notifications on news.